UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline

British journal of haematology, 2022-06, Vol.197 (5), p.558-572

2022

Volltextzugriff (PDF)

Guidelines for the first line management of classical Hodgkin lymphoma

British journal of haematology, 2014-07, Vol.166 (1), p.34-49

2014

Volltextzugriff (PDF)

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

British journal of haematology, 2020-08, Vol.190 (3), p.394-404

2020

Volltextzugriff (PDF)

Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy

British journal of haematology, 2015-08, Vol.170 (4), p.487-495

2015

Volltextzugriff (PDF)

Inferior vena cava malformation as a risk factor for deep venous thrombosis in the young

British journal of haematology, 2001-09, Vol.114 (4), p.878-880

2001

Volltextzugriff (PDF)

A retrospective study of autologous stem cell mobilization to guide an immediate salvage protocol using plerixafor for patients who mobilize stem cells poorly

Journal of clinical apheresis, 2013-10, Vol.28 (5), p.378-380

2013

Volltextzugriff (PDF)

Tumour lysis syndrome: new territory for a familiar foe?

British journal of haematology, 2015-06, Vol.169 (5), p.609-610

2015

Volltextzugriff (PDF)

CD4+ T‐cell responses to Epstein–Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV‐associated non‐Hodgkin lymphoma: Th1 in active disease but Tr1 in remission

British journal of haematology, 2007-10, Vol.139 (1), p.81-89

2007

Volltextzugriff (PDF)

Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma

British journal of haematology, 2002-11, Vol.119 (2), p.475-483

2002

Volltextzugriff (PDF)

Phase Ib study of eltrombopag and azacitidine in patients with high‐risk myelodysplastic syndromes and related disorders (the ELASTIC study)

British journal of haematology, 2022-10, Vol.199 (2), p.222-229

2022

Volltextzugriff (PDF)

Inflammatory profile of lower risk myelodysplastic syndromes

British journal of haematology, 2024-05

2024

Volltextzugriff (PDF)

Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial

British journal of haematology, 2020-04, Vol.189 (2), p.279-290

2020

Volltextzugriff (PDF)

Cause of death and excess mortality in patients with lower‐risk myelodysplastic syndromes (MDS): A report from the European MDS registry

British journal of haematology, 2023-02, Vol.200 (4), p.451-461

2023

Volltextzugriff (PDF)

British Society for Haematology guidelines for the management of adult myelodysplastic syndromes

British journal of haematology, 2021-07, Vol.194 (2), p.267-281

2021

Volltextzugriff (PDF)

British Society for Haematology guidelines for the diagnosis and evaluation of prognosis of Adult Myelodysplastic Syndromes

British journal of haematology, 2021-07, Vol.194 (2), p.282-293

2021

Volltextzugriff (PDF)

Guidelines for the diagnosis and management of adult myelodysplastic syndromes

British journal of haematology, 2014-02, Vol.164 (4), p.503-525

2014

Volltextzugriff (PDF)

De‐Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion‐dependent myelodysplastic syndromes

British journal of haematology, 2020-06, Vol.189 (6), p.e237-e240

2020

Volltextzugriff (PDF)

Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes

British journal of haematology, 2003-01, Vol.120 (2), p.187-200

2003

Volltextzugriff (PDF)

A randomised evaluation of low‐dose cytosine arabinoside (ara‐C) plus tosedostat versus low‐dose ara‐C in older patients with acute myeloid leukaemia: results of the LI‐1 trial

British journal of haematology, 2021-07, Vol.194 (2), p.298-308

2021

Volltextzugriff (PDF)

The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML

British journal of haematology, 2012-08, Vol.158 (4), p.519-522

2012

Volltextzugriff (PDF)

Results of a multicentre UK‐wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma

British journal of haematology, 2018-05, Vol.181 (4), p.555-559

2018

Volltextzugriff (PDF)

Clinical Bone Marrow and Blood Stem Cell Transplantation

British journal of haematology, 2001-01, Vol.112 (1), p.254-255

Culligan, Dominic

2001

Volltextzugriff (PDF)

Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway

British journal of haematology, 2000-11, Vol.111 (2), p.626-634

2000

Volltextzugriff (PDF)

CD4 super(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission

British journal of haematology, 2007-10, Vol.139 (1), p.81-89

2007

Volltextzugriff (PDF)

Leukaemia and Related Disorders: Edited by J. A. W hittaker and J. A. H olmes . Blackwell Science, Oxford, 1998. Pp. 568. £135.00

British journal of haematology, 1999-02, Vol.104 (2), p.427-427

Culligan, Dominic J.

1999

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(32)
Reviews
(2)

Sprache

Englisch
(34)
Japanisch
(3)

Erscheinungsjahr

n.n

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline

Guidelines for the first line management of classical Hodgkin lymphoma

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy

Inferior vena cava malformation as a risk factor for deep venous thrombosis in the young

A retrospective study of autologous stem cell mobilization to guide an immediate salvage protocol using plerixafor for patients who mobilize stem cells poorly

Tumour lysis syndrome: new territory for a familiar foe?

CD4+ T‐cell responses to Epstein–Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV‐associated non‐Hodgkin lymphoma: Th1 in active disease but Tr1 in remission

Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma

Phase Ib study of eltrombopag and azacitidine in patients with high‐risk myelodysplastic syndromes and related disorders (the ELASTIC study)

Inflammatory profile of lower risk myelodysplastic syndromes

Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial

Cause of death and excess mortality in patients with lower‐risk myelodysplastic syndromes (MDS): A report from the European MDS registry

British Society for Haematology guidelines for the management of adult myelodysplastic syndromes

British Society for Haematology guidelines for the diagnosis and evaluation of prognosis of Adult Myelodysplastic Syndromes

Guidelines for the diagnosis and management of adult myelodysplastic syndromes

De‐Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion‐dependent myelodysplastic syndromes

Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes

A randomised evaluation of low‐dose cytosine arabinoside (ara‐C) plus tosedostat versus low‐dose ara‐C in older patients with acute myeloid leukaemia: results of the LI‐1 trial

The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML

Results of a multicentre UK‐wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma

Clinical Bone Marrow and Blood Stem Cell Transplantation

Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway

CD4 super(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission

Leukaemia and Related Disorders: Edited by J. A. W hittaker and J. A. H olmes . Blackwell Science, Oxford, 1998. Pp. 568. £135.00

Aktive Filter

Suchergebnisse filtern